Sfoglia per Autore
Monoclonal antibodies as selective diagnostic and therapeutical tools in benign and neoplastic prostatic pathologies
2004-01-01 Vitale C, Zitella A, Rosso V, Maison B, Tizzani A, Horenstein AL, Deaglio S, Montironi R, Malavasi F
The tryptophan metabolism in the immune dysregulation of multiple myeloma
2007-01-01 Fiore F, Castella B, Assalto C, Zappia S, Hwang SY, Vitale C, Boccadoro M, Massaia M
The metabolism of mevalonate as a signaling pathway influencing tumor-host interactions and disease progression in chronic lymphocytic leukemia (CLL)
2008-01-01 M. Coscia; S. Peola; G. Matta; F. Pantaleoni; M. Foglietta; C. Vitale; D. Angelini; S. Chiaretti; C. Riganti; A. Guarini; D. Drandi; M. Ladetto; A. Bosia; R. Foà; L. Battistini; M. Boccadoro; J.J. Fournie; M. Massaia
THE LOCAL MICROENVIRONMENT PLAYS A DIFFERENT ROLE IN THE SURVIVAL OF TUMOR CELLS IN CHRONIC LYMPHOCYTIC LEUKEMIA WITH MUTATED AND UNMUTATED IMMUNOGLOBULIN (IG) VH GENES
2009-01-01 M. Coscia;1 F. Pantaleoni; C. Riganti; M. Rigoni; S. Peola; C. Vitale; D. Drandi; M. Ladetto; A. Bosia; M. Boccadoro; M. Massaia
PHENOTYPIC AND FUNCTIONAL FEATURES OF VGAMMA9/VDELTA2 T CELLS CORRELATE WITH THE MUTATIONAL STATUS OF THE TUMOR IMMUNOGLOBULINE AND WITH DISEASE AGGRESSIVENESS IN CHRONIC LYMPHOCYTIC LEUKEMIA
2009-01-01 Coscia M.; Peola S.; Pantaleoni F.; Matta G.M.; Foglietta M.; Vitale C.; Angelini D.F.; Chiaretti S.; Riganti C.; Guarini A.; Drandi D.; Ladetto M.; Bosia A.; Foà R.; Battistini L.; Boccadoro M.; Fournie J.J.; Massaia M.
THE SURVIVAL OF TUMOR CELLS IN IGVH UNMUTATED CHRONIC LYMPHOCYTIC LEUKEMIA IS HIGHLY DEPENDENT ON EXOGENOUS SIGNALS DELIVERED BY THE TUMOR MICROENVIRONMENT
2009-01-01 Coscia M; Pantaleoni F; Riganti C; Rigoni M; Vitale C; Peola S; Drandi D; Ladetto M; Bosia A; Boccadoro M; Massaia M.
Role of ward pharmacist in management of systemic antifungal drugs in hematology department of San Giovanni Battista Hospital, Turin, Italy.
2009-01-01 F. Cattel; M. Massaia; A. Gasco; M. Scaldaferri; A. Potenzieri; C. Vitale; E. Cerutti; S. Boffa; E.J. Pennone; L. Tomatis; S. Stecca.
Differential Effects of Microenvironmental Elements On Tumor Cells Survival in Chronic Lymphocytic Leukemia Patient Subsets with Good or Poor Prognosis
2009-01-01 Marta Coscia; Francesca Pantaleoni; Chiara Riganti; Micol Rigoni; Candida Vitale; Silvia Peola; Daniela Drandi; Marco Ladetto; Amalia Bosia; Mario Boccadoro; Massimo Massaia
Comprehensive assessment of the TCRBV repertoire in small T-cell samples by means of an improved and convenient multiplex PCR method
2009-01-01 Mariani S; Hwang SY; Foglietta M; Bonello L; Vitale C; Coscia M; Fiore F; Bruno B; Massaia M.
The role of clinical team pharmacist of San Giovanni Battista Hospital in a retrospective study invasive fungine infections: management and appropiateness.
2010-01-01 F. Cattel; M. Massaia; M. Scaldaferri; C. Vitale; M.E. Canepari; A. Potenzieri; S. Boffa; E. Cerutti; E.J. Pennone; E. Sciorsci; G. Fazzina; D. Barilà; A. Chiesa; S. Stecca
IGHV Unmutated Chronic Lymphocytic Leukemia (CLL) B Cells Are More Susceptible to Spontaneous Apoptosis Than Mutated CLL B Cells and Are Subject to the Anti-Apoptotic Effect of Environmental Signals
2010-01-01 Marta Coscia; Francesca Pantaleoni; Chiara Riganti; Candida Vitale; Micol Rigoni; Silvia Peola; Daniela Drandi; Barbara Castella; Marina Ruggeri; Paola Omedè; Marco Ladetto; Amalia Bosia; Mario Boccadoro; Massimo Massaia
BENDAMUSTINE AND ALEMTUZUMAB (BEN CAM) COMBINATION IN RELAPSED AND REFRACTORY CHRONIC LYMPHOCYTIC LEUKAEMIA (CLL): PHASE I SAFETY PROFILE RESULTS OF THE ITALIAN TRIAL
2010-01-01 A Tedeschi ;M Coscia ;D Rossi ;E Vismara ;F Ricci ;C Vitale ;E Morra ;G Gaidano ;M Massaia ;M Montillo
IDENTIFICATION BY SEROLOGICAL PROTEOME ANALYSIS (SERPA) OF TUMOR-ASSOCIATED ANTIGENS ELICITING ANTIBODY RESPONSES IN CHRONIC LYMPHOCYTIC LEUKEMIA (CLL)
2010-01-01 Marta Coscia; Michela Capello; Valentina Griggio; Federica Linty; Candida Vitale; Silvia Peola; Barbara Castella; Micol Rigoni; Daniela Drandi; Marina Ruggeri; Paola Omedè; Marco Ladetto; Franco Novelli; Mario Boccadoro; Massimo Massaia
The Defective Proliferation of Vgamma9Vdelta2 T Cells to Zoledronic Acid In Chronic Lymphocytic Leukemia (CLL) Is a Powerful Time to First Treatment (TFT) Predictor Associated with the IGHV Mutational Status.
2010-01-01 Marta Coscia; Candida Vitale; Silvia Peola; Chiara Riganti; Daniela Angelini; Myriam Foglietta; Francesca Pantaleoni; Giorgia Matta; Sabina Chiaretti; Anna Guarini; Daniela Drandi; Marco Ladetto; Amalia Bosia; Luca Battistini; Robin Foà; Mario Boccadoro; Jean-Jacques Fournié; Massimo Massaia
SEROLOGICAL PROTEOME ANALYSIS (SERPA) FOR THEIDENTIFICATION OF NOVEL TUMOR-ASSOCIATED ANTIGENS INCHRONIC LYMPHOCYTIC LEUKEMIA
2011-01-01 M. Coscia; V. Griggio; M. Capello; F. Linty; C. Vitale; S. Peola; B. Castella; M. Rigoni; D. Drandi; M. Ruggeri; P. Omede`; M. Ladetto; F. Novelli; M. Boccadoro; M. Massaia
Accelerated activity of the mevalonate pathway supports the immune escape and multidrug-resistance phenotype of IGHV unmutated chronic lymphocytic leukemia cells
2011-01-01 M Coscia; M Rigoni; C Riganti; I Campia; C Vitale; V Griggio; S Peola; B Castella; F Pantaleoni; P Sciancalepore; D Drandi; P Omedè; M Ladetto; A Bosia; M Boccadoro; M Massaia
IGHV UNMUTATED CLL B CELLS ARE MORE PRONE TO SPONTANEOUS APOPTOSIS AND DEPEND FROM THE ANTI-APOPTOTIC EFFECT OF ENVIRONMENTAL SIGNALS
2011-01-01 Marta Coscia; Francesca Pantaleoni; Chiara Riganti; Candida Vitale; Micol Rigoni; Silvia Peola; Daniela Drandi; Marco Ladetto; Marina Ruggeri; Valentina Griggio; Barbara Castella; Patrizia Sciancalepore; Paola Omedè; Amalia Bosia; Mario Boccadoro; Massimo Massaia
Identification by serological proteome analysis (SERPA) of tumor-associated antigens eliciting antibody-responses in chronic lymphocytic leukemia
2011-01-01 Griggio V; Capello M; Linty F; Vitale C; Peola S; Cappello P; Castella B; Rigoni M; Sciancalepore P; Drandi D; Ruggeri M; Omedè P; Ladetto M; Novelli F; Boccadoro M; Massaia M; Coscia M
IMPACT OF THE MEVALONATE PATHWAY AND HIF/PGP AXIS IN MODULATING MULTIDRUG-RESISTANCE IN UNMUTATED CLL CELLS
2011-01-01 Marta Coscia; Micol Rigoni; Chiara Riganti; Ivana Campia; Candida Vitale; Silvia Peola; Barbara Castella; Valentina Griggio; Francesca Pantaleoni; Patrizia Sciancalepore; Daniela Drandi; Marco Ladetto; Amalia Bosia; Mario Boccadoro; Massimo Massaia
Bendamustine and alemtuzumab (BEN CAM) combination in relapsed and refractory chronic lymphocytic leukaemia (CLL): interim report of the italian trial
2011-01-01 A Tedeschi; M Coscia; D Rossi; F Ricci; G D'Arena; E Orlandi; V Belsito Petrizzi; L Scarfò; C Vitale; E Vismara; G Gaidano; E Morra; M Massaia; M Montillo
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Monoclonal antibodies as selective diagnostic and therapeutical tools in benign and neoplastic prostatic pathologies | 2004 | Vitale C, Zitella A, Rosso V, Maison B, Tizzani A, Horenstein AL, Deaglio S, Montironi R, Malavasi F | |
| The tryptophan metabolism in the immune dysregulation of multiple myeloma | 2007 | Fiore F, Castella B, Assalto C, Zappia S, Hwang SY, Vitale C, Boccadoro M, Massaia M | |
| The metabolism of mevalonate as a signaling pathway influencing tumor-host interactions and disease progression in chronic lymphocytic leukemia (CLL) | 2008 | M. Coscia; S. Peola; G. Matta; F. Pantaleoni; M. Foglietta; C. Vitale; D. Angelini; S. Chiaretti; C. Riganti; A. Guarini; D. Drandi; M. Ladetto; A. Bosia; R. Foà; L. Battistini; M. Boccadoro; J.J. Fournie; M. Massaia | |
| THE LOCAL MICROENVIRONMENT PLAYS A DIFFERENT ROLE IN THE SURVIVAL OF TUMOR CELLS IN CHRONIC LYMPHOCYTIC LEUKEMIA WITH MUTATED AND UNMUTATED IMMUNOGLOBULIN (IG) VH GENES | 2009 | M. Coscia;1 F. Pantaleoni; C. Riganti; M. Rigoni; S. Peola; C. Vitale; D. Drandi; M. Ladetto; A. Bosia; M. Boccadoro; M. Massaia | |
| PHENOTYPIC AND FUNCTIONAL FEATURES OF VGAMMA9/VDELTA2 T CELLS CORRELATE WITH THE MUTATIONAL STATUS OF THE TUMOR IMMUNOGLOBULINE AND WITH DISEASE AGGRESSIVENESS IN CHRONIC LYMPHOCYTIC LEUKEMIA | 2009 | Coscia M.; Peola S.; Pantaleoni F.; Matta G.M.; Foglietta M.; Vitale C.; Angelini D.F.; Chiaretti S.; Riganti C.; Guarini A.; Drandi D.; Ladetto M.; Bosia A.; Foà R.; Battistini L.; Boccadoro M.; Fournie J.J.; Massaia M. | |
| THE SURVIVAL OF TUMOR CELLS IN IGVH UNMUTATED CHRONIC LYMPHOCYTIC LEUKEMIA IS HIGHLY DEPENDENT ON EXOGENOUS SIGNALS DELIVERED BY THE TUMOR MICROENVIRONMENT | 2009 | Coscia M; Pantaleoni F; Riganti C; Rigoni M; Vitale C; Peola S; Drandi D; Ladetto M; Bosia A; Boccadoro M; Massaia M. | |
| Role of ward pharmacist in management of systemic antifungal drugs in hematology department of San Giovanni Battista Hospital, Turin, Italy. | 2009 | F. Cattel; M. Massaia; A. Gasco; M. Scaldaferri; A. Potenzieri; C. Vitale; E. Cerutti; S. Boffa; E.J. Pennone; L. Tomatis; S. Stecca. | |
| Differential Effects of Microenvironmental Elements On Tumor Cells Survival in Chronic Lymphocytic Leukemia Patient Subsets with Good or Poor Prognosis | 2009 | Marta Coscia; Francesca Pantaleoni; Chiara Riganti; Micol Rigoni; Candida Vitale; Silvia Peola; Daniela Drandi; Marco Ladetto; Amalia Bosia; Mario Boccadoro; Massimo Massaia | |
| Comprehensive assessment of the TCRBV repertoire in small T-cell samples by means of an improved and convenient multiplex PCR method | 2009 | Mariani S; Hwang SY; Foglietta M; Bonello L; Vitale C; Coscia M; Fiore F; Bruno B; Massaia M. | |
| The role of clinical team pharmacist of San Giovanni Battista Hospital in a retrospective study invasive fungine infections: management and appropiateness. | 2010 | F. Cattel; M. Massaia; M. Scaldaferri; C. Vitale; M.E. Canepari; A. Potenzieri; S. Boffa; E. Cerutti; E.J. Pennone; E. Sciorsci; G. Fazzina; D. Barilà; A. Chiesa; S. Stecca | |
| IGHV Unmutated Chronic Lymphocytic Leukemia (CLL) B Cells Are More Susceptible to Spontaneous Apoptosis Than Mutated CLL B Cells and Are Subject to the Anti-Apoptotic Effect of Environmental Signals | 2010 | Marta Coscia; Francesca Pantaleoni; Chiara Riganti; Candida Vitale; Micol Rigoni; Silvia Peola; Daniela Drandi; Barbara Castella; Marina Ruggeri; Paola Omedè; Marco Ladetto; Amalia Bosia; Mario Boccadoro; Massimo Massaia | |
| BENDAMUSTINE AND ALEMTUZUMAB (BEN CAM) COMBINATION IN RELAPSED AND REFRACTORY CHRONIC LYMPHOCYTIC LEUKAEMIA (CLL): PHASE I SAFETY PROFILE RESULTS OF THE ITALIAN TRIAL | 2010 | A Tedeschi ;M Coscia ;D Rossi ;E Vismara ;F Ricci ;C Vitale ;E Morra ;G Gaidano ;M Massaia ;M Montillo | |
| IDENTIFICATION BY SEROLOGICAL PROTEOME ANALYSIS (SERPA) OF TUMOR-ASSOCIATED ANTIGENS ELICITING ANTIBODY RESPONSES IN CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) | 2010 | Marta Coscia; Michela Capello; Valentina Griggio; Federica Linty; Candida Vitale; Silvia Peola; Barbara Castella; Micol Rigoni; Daniela Drandi; Marina Ruggeri; Paola Omedè; Marco Ladetto; Franco Novelli; Mario Boccadoro; Massimo Massaia | |
| The Defective Proliferation of Vgamma9Vdelta2 T Cells to Zoledronic Acid In Chronic Lymphocytic Leukemia (CLL) Is a Powerful Time to First Treatment (TFT) Predictor Associated with the IGHV Mutational Status. | 2010 | Marta Coscia; Candida Vitale; Silvia Peola; Chiara Riganti; Daniela Angelini; Myriam Foglietta; Francesca Pantaleoni; Giorgia Matta; Sabina Chiaretti; Anna Guarini; Daniela Drandi; Marco Ladetto; Amalia Bosia; Luca Battistini; Robin Foà; Mario Boccadoro; Jean-Jacques Fournié; Massimo Massaia | |
| SEROLOGICAL PROTEOME ANALYSIS (SERPA) FOR THEIDENTIFICATION OF NOVEL TUMOR-ASSOCIATED ANTIGENS INCHRONIC LYMPHOCYTIC LEUKEMIA | 2011 | M. Coscia; V. Griggio; M. Capello; F. Linty; C. Vitale; S. Peola; B. Castella; M. Rigoni; D. Drandi; M. Ruggeri; P. Omede`; M. Ladetto; F. Novelli; M. Boccadoro; M. Massaia | |
| Accelerated activity of the mevalonate pathway supports the immune escape and multidrug-resistance phenotype of IGHV unmutated chronic lymphocytic leukemia cells | 2011 | M Coscia; M Rigoni; C Riganti; I Campia; C Vitale; V Griggio; S Peola; B Castella; F Pantaleoni; P Sciancalepore; D Drandi; P Omedè; M Ladetto; A Bosia; M Boccadoro; M Massaia | |
| IGHV UNMUTATED CLL B CELLS ARE MORE PRONE TO SPONTANEOUS APOPTOSIS AND DEPEND FROM THE ANTI-APOPTOTIC EFFECT OF ENVIRONMENTAL SIGNALS | 2011 | Marta Coscia; Francesca Pantaleoni; Chiara Riganti; Candida Vitale; Micol Rigoni; Silvia Peola; Daniela Drandi; Marco Ladetto; Marina Ruggeri; Valentina Griggio; Barbara Castella; Patrizia Sciancalepore; Paola Omedè; Amalia Bosia; Mario Boccadoro; Massimo Massaia | |
| Identification by serological proteome analysis (SERPA) of tumor-associated antigens eliciting antibody-responses in chronic lymphocytic leukemia | 2011 | Griggio V; Capello M; Linty F; Vitale C; Peola S; Cappello P; Castella B; Rigoni M; Sciancalepore P; Drandi D; Ruggeri M; Omedè P; Ladetto M; Novelli F; Boccadoro M; Massaia M; Coscia M | |
| IMPACT OF THE MEVALONATE PATHWAY AND HIF/PGP AXIS IN MODULATING MULTIDRUG-RESISTANCE IN UNMUTATED CLL CELLS | 2011 | Marta Coscia; Micol Rigoni; Chiara Riganti; Ivana Campia; Candida Vitale; Silvia Peola; Barbara Castella; Valentina Griggio; Francesca Pantaleoni; Patrizia Sciancalepore; Daniela Drandi; Marco Ladetto; Amalia Bosia; Mario Boccadoro; Massimo Massaia | |
| Bendamustine and alemtuzumab (BEN CAM) combination in relapsed and refractory chronic lymphocytic leukaemia (CLL): interim report of the italian trial | 2011 | A Tedeschi; M Coscia; D Rossi; F Ricci; G D'Arena; E Orlandi; V Belsito Petrizzi; L Scarfò; C Vitale; E Vismara; G Gaidano; E Morra; M Massaia; M Montillo |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile